Researchers combined data from multiple studies to examine brain differences in Wilson's disease. They used a specific MRI method called quantitative susceptibility mapping to measure signals in deep gray matter regions. The group included 325 individuals with Wilson's disease and 254 healthy controls for comparison. The search for these studies was completed in September 2025 using major medical databases.
The analysis revealed that people with neurological Wilson's disease had higher susceptibility signals in the caudate, putamen, globus pallidus, thalamus, red nucleus, and dentate nucleus compared to healthy controls. When comparing neurological-onset Wilson's disease to hepatic-onset forms, the neurological group also showed higher susceptibility in the caudate, putamen, and thalamus. People with hepatic-onset disease showed milder increases in some areas compared to healthy controls.
These results suggest that quantitative susceptibility mapping can detect specific brain changes in Wilson's disease. The study did not report any safety concerns or adverse events because it analyzed existing imaging data rather than testing a new treatment. Readers should understand that this is an observational analysis linking brain signals to disease type. More research is needed to determine if these findings can help diagnose the disease earlier or guide treatment decisions in clinical practice.
